{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:36:59Z","timestamp":1791286619625,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1038\/ncpendmet0324","type":"journal-article","created":{"date-parts":[[2006,12,4]],"date-time":"2006-12-04T11:31:03Z","timestamp":1165231863000},"page":"681-693","source":"Crossref","is-referenced-by-count":69,"title":["Mechanisms of Disease: mutations of G proteins and G-protein-coupled receptors in endocrine diseases"],"prefix":"10.1038","volume":"2","author":[{"given":"Andrea G","family":"Lania","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFncpendmet0324_CR1","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1124\/mol.104.009001","volume":"67","author":"R Fredriksson","year":"2005","unstructured":"Fredriksson R and Schioth HB (2005) The repertoire of G-protein-coupled receptors in fully sequenced genomes. Mol Pharmacol 67: 1414\u20131425","journal-title":"Mol Pharmacol"},{"key":"BFncpendmet0324_CR2","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1097\/00000542-200511000-00022","volume":"103","author":"MW Hollmann","year":"2005","unstructured":"Hollmann MW et al. (2005) Receptors, G proteins and their interactions. Anesthesiology 103: 1066\u20131078","journal-title":"Anesthesiology"},{"key":"BFncpendmet0324_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1124\/pr.57.2.2","volume":"57","author":"DM Perez","year":"2005","unstructured":"Perez DM and Karnik SS (2005) Multiple signaling states of G-protein-coupled receptors. Pharmacol Rev 57: 147\u2013161","journal-title":"Pharmacol Rev"},{"key":"BFncpendmet0324_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev.med.55.091902.103843","volume":"55","author":"AM Spiegel","year":"2004","unstructured":"Spiegel AM and Weinstein LS (2004) Inherited diseases involving G proteins and G protein-coupled receptors. Annu Rev Med 55: 27\u201339","journal-title":"Annu Rev Med"},{"key":"BFncpendmet0324_CR5","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1210\/me.2004-0091","volume":"18","author":"SP Brothers","year":"2004","unstructured":"Brothers SP et al. (2004) Human loss-of-function gonadotropin-releasing hormone receptor mutants retain wild-type receptors in the endoplasmic reticulum: molecular basis of the dominant-negative effect. Mol Endocrinol 18: 1787\u20131797","journal-title":"Mol Endocrinol"},{"key":"BFncpendmet0324_CR6","first-page":"1561","volume":"82","author":"R Collu","year":"1997","unstructured":"Collu R et al. (1997) A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. J Clin Endocrinol Metab 82: 1561\u20131565","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0324_CR7","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1172\/JCI119497","volume":"99","author":"MJ Abramowicz","year":"1997","unstructured":"Abramowicz MJ et al. (1997) Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland. J Clin Invest 99: 3018\u20133024","journal-title":"J Clin Invest"},{"key":"BFncpendmet0324_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1056\/NEJM199501193320305","volume":"332","author":"T Sunthornthepvarakul","year":"1995","unstructured":"Sunthornthepvarakul T et al. (1995) Resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene. N Engl J Med 332: 155\u2013160","journal-title":"N Engl J Med"},{"key":"BFncpendmet0324_CR9","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1172\/JCI26031","volume":"115","author":"TF Davies","year":"2005","unstructured":"Davies TF et al. (2005) Thyrotropin receptor-associated diseases: from adenomas to Graves disease. J Clin Invest 115: 1972\u20131983","journal-title":"J Clin Invest"},{"key":"BFncpendmet0324_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/365649a0","volume":"365","author":"J Parma","year":"1993","unstructured":"Parma J et al. (1993) Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365: 649\u2013651","journal-title":"Nature"},{"key":"BFncpendmet0324_CR11","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1210\/er.2004-0005","volume":"26","author":"K Krohn","year":"2005","unstructured":"Krohn K et al. (2005) Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev 26: 504\u2013524","journal-title":"Endocr Rev"},{"key":"BFncpendmet0324_CR12","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.1210\/jcem.82.12.4405","volume":"82","author":"Fuhrer","year":"1997","unstructured":"Fuhrer et al. (1997) Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism. J Clin Endocrinol Metab 82: 4234\u20134238","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0324_CR13","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJM199812173392505","volume":"339","author":"P Rodien","year":"1998","unstructured":"Rodien P et al. (1998) Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 339: 1823\u20131826","journal-title":"N Engl J Med"},{"key":"BFncpendmet0324_CR14","doi-asserted-by":"publisher","first-page":"10972","DOI":"10.1073\/pnas.1834399100","volume":"100","author":"N de Roux","year":"2003","unstructured":"de Roux N et al. (2003) Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci USA 100: 10972\u201310976","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpendmet0324_CR15","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJM199711273372205","volume":"337","author":"N de Roux","year":"1997","unstructured":"de Roux N et al. (1997) A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N Engl J Med 337: 1597\u20131602","journal-title":"N Engl J Med"},{"key":"BFncpendmet0324_CR16","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/humupd\/dmg040","volume":"9","author":"B Karges","year":"2003","unstructured":"Karges B et al. (2003) Clinical and molecular genetics of the human GnRH receptor. Hum Reprod Update 9: 523\u2013530","journal-title":"Hum Reprod Update"},{"key":"BFncpendmet0324_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1530\/eje.0.1390157","volume":"139","author":"P Chanson","year":"1998","unstructured":"Chanson P et al. (1998) Absence of activating mutations in the GnRH receptor gene in human pituitary gonadotroph adenomas. Eur J Endocrinol 139: 157\u2013160","journal-title":"Eur J Endocrinol"},{"key":"BFncpendmet0324_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1530\/rep.1.00663","volume":"130","author":"APN Themmen","year":"2005","unstructured":"Themmen APN (2005) An update of the pathophysiology of human gonadotropin subunit and receptor gene mutations and polymorphisms. Reproduction 130: 263\u2013274","journal-title":"Reproduction"},{"key":"BFncpendmet0324_CR19","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1056\/NEJM197610282951801","volume":"295","author":"F Berthezene","year":"1976","unstructured":"Berthezene F et al. (1976) Leydig-cell agenesis: a cause of male pseudohermaphroditism. N Engl J Med 295: 969\u2013972","journal-title":"N Engl J Med"},{"key":"BFncpendmet0324_CR20","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/365652a0","volume":"365","author":"A Shenker","year":"1993","unstructured":"Shenker A et al. (1993) A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365: 652\u2013654","journal-title":"Nature"},{"key":"BFncpendmet0324_CR21","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1056\/NEJM199912023412304","volume":"341","author":"G Liu","year":"1999","unstructured":"Liu G et al. (1999) Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 341: 1731\u20131736","journal-title":"N Engl J Med"},{"key":"BFncpendmet0324_CR22","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/0092-8674(95)90275-9","volume":"82","author":"K Aittomaki","year":"1995","unstructured":"Aittomaki K et al. (1995) Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82: 959\u2013968","journal-title":"Cell"},{"key":"BFncpendmet0324_CR23","first-page":"1367","volume":"81","author":"J Gromoll","year":"1996","unstructured":"Gromoll J et al. (1996) An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J Clin Endocrinol Metab 81: 1367\u20131370","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0324_CR24","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1056\/NEJMp038106","volume":"349","author":"UB Kaiser","year":"2003","unstructured":"Kaiser UB (2003) The pathogenesis of the ovarian hyperstimulation syndrome. N Engl J Med 349: 729\u2013732","journal-title":"N Engl J Med"},{"key":"BFncpendmet0324_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0140-6736(93)90208-X","volume":"341","author":"AJ Clark","year":"1993","unstructured":"Clark AJ et al. (1993) Familial glucocorticoid deficiency associated with a point mutation in the adrenocorticotropin receptor. Lancet 341: 461\u2013462","journal-title":"Lancet"},{"key":"BFncpendmet0324_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.tem.2005.10.006","volume":"16","author":"AJ Clark","year":"2005","unstructured":"Clark AJ et al. (2005) Inherited ACTH insensitivity illuminates the mechanisms of ACTH action. Trends Endocrinol Metab 16: 451\u2013457","journal-title":"Trends Endocrinol Metab"},{"key":"BFncpendmet0324_CR27","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1056\/NEJM199210013271402","volume":"327","author":"A Lacroix","year":"1992","unstructured":"Lacroix A et al. (1992) Gastric inhibitory polypeptide-dependent cortisol hypersecretion: a new cause of Cushing's syndrome. N Engl J Med 327: 974\u2013980","journal-title":"N Engl J Med"},{"key":"BFncpendmet0324_CR28","first-page":"75","volume":"22","author":"A Lacroix","year":"2001","unstructured":"Lacroix A et al. (2001) Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev 22: 75\u2013110","journal-title":"Endocr Rev"},{"key":"BFncpendmet0324_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/2404","volume":"20","author":"GS Yeo","year":"1998","unstructured":"Yeo GS et al. (1998) A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat Genet 20: 111\u2013112","journal-title":"Nat Genet"},{"key":"BFncpendmet0324_CR30","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev.med.56.062904.144924","volume":"56","author":"IS Farooqi","year":"2005","unstructured":"Farooqi IS and O'Rahilly S (2005) Monogenic obesity in humans. Annu Rev Med 56: 443\u2013458","journal-title":"Annu Rev Med"},{"key":"BFncpendmet0324_CR31","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/j.peptides.2004.11.042","volume":"26","author":"C Govaerts","year":"2005","unstructured":"Govaerts C et al. (2005) Obesity-associated mutations in the melanocortin 4 receptor provide novel insights into its function. Peptides 26: 1909\u20131919","journal-title":"Peptides"},{"key":"BFncpendmet0324_CR32","first-page":"4065","volume":"83","author":"HG Maheshwari","year":"1998","unstructured":"Maheshwari HG et al. (1998) Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: dwarfism of Sindh. J Clin Endocrinol Metab 83: 4065\u20134074","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0324_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0083-6729(04)69007-8","volume":"69","author":"M Alba","year":"2004","unstructured":"Alba M and Salvatori R (2004) Familial growth hormone deficiency and mutations in the GHRH receptor gene. Vitam Horm 69: 209\u2013220","journal-title":"Vitam Horm"},{"key":"BFncpendmet0324_CR34","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1210\/jcem.86.8.7732","volume":"86","author":"EJ Lee","year":"2001","unstructured":"Lee EJ et al. (2001) Absence of constitutively activating mutations in the GHRH receptor in GH-producing pituitary tumors. J Clin Endocrinol Metab 86: 3989\u20133995","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0324_CR35","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1172\/JCI25303","volume":"116","author":"J Pantel","year":"2006","unstructured":"Pantel J et al. (2006) Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest 116: 760\u2013768","journal-title":"J Clin Invest"},{"key":"BFncpendmet0324_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/359233a0","volume":"359","author":"W Rosenthal","year":"1992","unstructured":"Rosenthal W et al. (1992) Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 359: 233\u2013235","journal-title":"Nature"},{"key":"BFncpendmet0324_CR37","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1007\/s004670100051","volume":"16","author":"NV Knoers","year":"2001","unstructured":"Knoers NV and Deen PM (2001) Molecular and cellular defects in nephrogenic diabetes insipidus. Pediatr Nephrol 16: 1146\u20131152","journal-title":"Pediatr Nephrol"},{"key":"BFncpendmet0324_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/BF00214189","volume":"96","author":"AF van Lieburg","year":"1995","unstructured":"van Lieburg AF et al. (1995) Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation. Hum Genet 96: 70\u201378","journal-title":"Hum Genet"},{"key":"BFncpendmet0324_CR39","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1210\/jcem.82.10.4312","volume":"82","author":"Y Nomura","year":"1997","unstructured":"Nomura Y et al. (1997) Detection of skewed X-inactivation in two female carriers of vasopressin type 2 receptor gene mutation. J Clin Endocrinol Metab 82: 3434\u20133437","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0324_CR40","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1681\/ASN.V9101861","volume":"9","author":"Y Ala","year":"1998","unstructured":"Ala Y et al. (1998) Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol 9: 1861\u20131872","journal-title":"J Am Soc Nephrol"},{"key":"BFncpendmet0324_CR41","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1056\/NEJMoa042743","volume":"352","author":"BJ Feldman","year":"2005","unstructured":"Feldman BJ et al. (2005) Nephrogenic syndrome of inappropriate antidiuresis. N Engl J Med 352: 1884\u20131889","journal-title":"N Engl J Med"},{"key":"BFncpendmet0324_CR42","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","volume":"75","author":"MR Pollak","year":"1993","unstructured":"Pollak MR et al. (1993) Mutations in the human Ca2 sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75: 1297\u20131303","journal-title":"Cell"},{"key":"BFncpendmet0324_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ceca.2003.10.010","volume":"35","author":"RV Thakker","year":"2004","unstructured":"Thakker RV (2004) Diseases associated with the extracellular calcium-sensing receptor. Cell Calcium 35: 275\u2013282","journal-title":"Cell Calcium"},{"key":"BFncpendmet0324_CR44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/1098-1004(200010)16:4<281::AID-HUMU1>3.0.CO;2-A","volume":"16","author":"GN Hendy","year":"2000","unstructured":"Hendy GN et al. (2000) Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 16: 281\u2013296","journal-title":"Hum Mutat"},{"key":"BFncpendmet0324_CR45","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/hmg\/5.5.601","volume":"5","author":"J Baron","year":"1996","unstructured":"Baron J et al. (1996) Mutations in the Ca2-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Hum Mol Genet 5: 601\u2013606","journal-title":"Hum Mol Genet"},{"key":"BFncpendmet0324_CR46","first-page":"363","volume":"84","author":"R Okazaki","year":"1999","unstructured":"Okazaki R et al. (1999) A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia. J Clin Endocrinol Metab 84: 363\u2013366","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0324_CR47","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s004390050174","volume":"98","author":"K Lovlie","year":"1996","unstructured":"Lovlie K et al. (1996) The Ca2 sensing receptor gene (PCAR1) mutation T151M in isolated autosomal dominant hypoparathyroidism. Hum Genet 98: 129\u2013133","journal-title":"Hum Genet"},{"key":"BFncpendmet0324_CR48","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1210\/jcem.86.11.8016","volume":"86","author":"A Lienhardt","year":"2001","unstructured":"Lienhardt A et al. (2001) Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab 86: 5313\u20135323","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0324_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1172\/JCI2918","volume":"102","author":"A-S Jobert","year":"1998","unstructured":"Jobert A-S et al. (1998) Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest 102: 34\u201340","journal-title":"J Clin Invest"},{"key":"BFncpendmet0324_CR50","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1056\/NEJM199609053351004","volume":"335","author":"E Schipani","year":"1996","unstructured":"Schipani E et al. (1996) Constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. N Engl J Med 335: 708\u2013714","journal-title":"N Engl J Med"},{"key":"BFncpendmet0324_CR51","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1126\/science.2116665","volume":"249","author":"Lyons","year":"1990","unstructured":"Lyons et al. (1990) Two G protein oncogenes in human endocrine tumors. Science 249: 655\u2013659","journal-title":"Science"},{"key":"BFncpendmet0324_CR52","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1152\/physrev.00003.2005","volume":"85","author":"N Wettschureck","year":"2005","unstructured":"Wettschureck N and Offermanns S (2005) Mammalian G proteins and their cell type specific functions. Physiol Rev 85: 1159\u20131204","journal-title":"Physiol Rev"},{"key":"BFncpendmet0324_CR53","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/ng0796-358","volume":"13","author":"TP Dryja","year":"1996","unstructured":"Dryja TP et al. (1996) Missense mutation in the gene encoding the \u03b1 subunit of rod transducin in the Nougaret form of congenital stationary night blindness. Nat Genet 13: 358\u2013360","journal-title":"Nat Genet"},{"key":"BFncpendmet0324_CR54","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.1210\/en.2004-0865","volume":"145","author":"LS Weinstein","year":"2004","unstructured":"Weinstein LS et al. (2004) Minireview: GNAS: normal and abnormal functions. Endocrinology 145: 5459\u20135464","journal-title":"Endocrinology"},{"key":"BFncpendmet0324_CR55","doi-asserted-by":"publisher","first-page":"8287","DOI":"10.1073\/pnas.87.21.8287","volume":"87","author":"LS Weinstein","year":"1990","unstructured":"Weinstein LS et al. (1990) Mutations of the Gs\u03b1-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc Natl Acad Sci USA 87: 8287\u20138290","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpendmet0324_CR56","first-page":"675","volume":"22","author":"LS Weinstein","year":"2001","unstructured":"Weinstein LS et al. (2001) Endocrine manifestations of stimulatory G protein \u03b1-subunit mutations and the role of genomic imprinting. Endocr Rev 22: 675\u2013705","journal-title":"Endocr Rev"},{"key":"BFncpendmet0324_CR57","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1210\/jc.2002-022028","volume":"88","author":"G Mantovani","year":"2003","unstructured":"Mantovani G et al. (2003) Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type Ia: new evidence for imprinting of the Gs\u03b1 gene. J Clin Endocrinol Metab 88: 4070\u20134074","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0324_CR58","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1210\/jc.2003-030028","volume":"88","author":"EL Germain-Lee","year":"2003","unstructured":"Germain-Lee EL et al. (2003) Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance. J Clin Endocrinol Metab 88: 4059\u20134069","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0324_CR59","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.1210\/jc.2002-020183","volume":"87","author":"G Mantovani","year":"2002","unstructured":"Mantovani G et al. (2002) The Gs\u03b1 gene: predominant maternal origin of transcription in human thyroid gland and gonads. J Clin Endocrinol Metab 87: 4736\u20134740","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0324_CR60","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1172\/JCI11887","volume":"107","author":"BE Hayward","year":"2001","unstructured":"Hayward BE et al. (2001) Imprinting of the Gs\u03b1 gene GNAS1 in the pathogenesis of acromegaly. J Clin Invest 107: R31\u2013R36","journal-title":"J Clin Invest"},{"key":"BFncpendmet0324_CR61","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1056\/NEJMoa011262","volume":"346","author":"EM Shore","year":"2002","unstructured":"Shore EM et al. (2002) Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. N Engl J Med 346: 99\u2013106","journal-title":"N Engl J Med"},{"key":"BFncpendmet0324_CR62","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/371164a0","volume":"371","author":"T Iiri","year":"1994","unstructured":"Iiri T et al. (1994) Rapid GDP release from Gs\u03b1 in patients with gain and loss of endocrine function. Nature 371: 164\u2013168","journal-title":"Nature"},{"key":"BFncpendmet0324_CR63","doi-asserted-by":"publisher","first-page":"11798","DOI":"10.1073\/pnas.95.20.11798","volume":"95","author":"H Juppner","year":"1998","unstructured":"Juppner H et al. (1998) The gene responsible for pseudohypoparathyroidism type Ib is paternally imprinted and maps in four unrelated kindreds to chromosome 20q13.3. Proc Natl Acad Sci USA 95: 11798\u201311803","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFncpendmet0324_CR64","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1086\/429932","volume":"76","author":"A Linglart","year":"2005","unstructured":"Linglart A et al. (2005) A novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS. Am J Hum Genet 76: 804\u2013814","journal-title":"Am J Hum Genet"},{"key":"BFncpendmet0324_CR65","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng1487","volume":"37","author":"M Bastepe","year":"2005","unstructured":"Bastepe M et al. (2005) Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib. Nat Genet 37: 25\u201327","journal-title":"Nat Genet"},{"key":"BFncpendmet0324_CR66","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/hmg\/ddi009","volume":"14","author":"J Liu","year":"2005","unstructured":"Liu J et al. (2005) Distinct patterns of abnormal GNAS imprinting in familial and sporadic pseudohypoparathyroidism type IB. Hum Mol Genet 14: 95\u2013102","journal-title":"Hum Mol Genet"},{"key":"BFncpendmet0324_CR67","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/340692a0","volume":"340","author":"CA Landis","year":"1989","unstructured":"Landis CA et al. (1989) GTPase inhibiting mutations activate the \u03b1 chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340: 692\u2013696","journal-title":"Nature"},{"key":"BFncpendmet0324_CR68","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1530\/eje.0.1450543","volume":"145","author":"A Lania","year":"2001","unstructured":"Lania A et al. (2001) G-protein mutations in endocrine diseases. Eur J Endocrinol 145: 543\u2013559","journal-title":"Eur J Endocrinol"},{"key":"BFncpendmet0324_CR69","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jpeds.2004.05.025","volume":"145","author":"R Roman","year":"2004","unstructured":"Roman R et al. (2004) Activating GNAS1 gene mutations in patients with premature thelarche. J Pediatr 145: 218\u2013222","journal-title":"J Pediatr"},{"key":"BFncpendmet0324_CR70","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1210\/jc.2005-2710","volume":"91","author":"N Kalfa","year":"2006","unstructured":"Kalfa N et al. (2006) Activating mutations of the stimulatory G protein in juvenile ovarian granulosa cell tumors: a new prognostic factor? J Clin Endocrinol Metab 91: 1842\u20131847","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0324_CR71","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1210\/jcem-71-6-1421","volume":"71","author":"A Spada","year":"1990","unstructured":"Spada A et al. (1990) Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase. J Clin Endocrinol Metab 71: 1421\u20131426","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0324_CR72","first-page":"1624","volume":"83","author":"A Lania","year":"1998","unstructured":"Lania A et al. (1998) Constitutively active Gs\u03b1 is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas. J Clin Endocrinol Metab 83: 1624\u20131628","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0324_CR73","first-page":"4386","volume":"83","author":"E Ballare","year":"1998","unstructured":"Ballare E et al. (1998) Activating mutations of the Gs\u03b1 gene are associated with low levels of Gs\u03b1 protein in growth hormone-secreting tumors. J Clin Endocrinol Metab 83: 4386\u20134390","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0324_CR74","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","volume":"325","author":"LS Weinstein","year":"1991","unstructured":"Weinstein LS et al. (1991) Activating mutations of the stimulatory G protein in the McCune\u2013Albright syndrome. N Engl J Med 325: 1688\u20131695","journal-title":"N Engl J Med"},{"key":"BFncpendmet0324_CR75","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1210\/jc.2004-0194","volume":"89","author":"G Mantovani","year":"2004","unstructured":"Mantovani G et al. (2004) A parental origin of Gs\u03b1 mutations in the McCune\u2013Albright syndrome and in isolated endocrine tumors. J Clin Endocrinol Metab 89: 3007\u20133009","journal-title":"J Clin Endocrinol Metab"},{"key":"BFncpendmet0324_CR76","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/hmg\/4.9.1675","volume":"4","author":"A Shenker","year":"1995","unstructured":"Shenker A et al. (1995) Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the Gs\u03b1 gene. Hum Mol Genet 4: 1675\u20131676","journal-title":"Hum Mol Genet"},{"key":"BFncpendmet0324_CR77","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/10408360591001895","volume":"42","author":"MD Thompson","year":"2005","unstructured":"Thompson MD et al. (2005) The G protein-coupled receptors: pharmacogenetics and disease. Crit Rev Clin Lab Sci 42: 311\u2013392","journal-title":"Crit Rev Clin Lab Sci"},{"key":"BFncpendmet0324_CR78","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.tem.2005.05.011","volume":"8","author":"J Gromoll","year":"2005","unstructured":"Gromoll J and Simoni E (2005) Genetic complexity of FSH receptor function. Trends Endocrinol Metab 8: 368\u2013373","journal-title":"Trends Endocrinol Metab"},{"key":"BFncpendmet0324_CR79","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/01.HYP.34.1.8","volume":"34","author":"H Jia","year":"1999","unstructured":"Jia H et al. (1999) Association of the Gs\u03b1 gene with essential hypertension and response to \u03b2-blockade. Hypertension 34: 8\u201314","journal-title":"Hypertension"},{"key":"BFncpendmet0324_CR80","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev.med.56.082103.104625","volume":"56","author":"W Siffert","year":"2005","unstructured":"Siffert W (2005) G protein polymorphisms in hypertension, atherosclerosis, and diabetes. Annu Rev Med 56: 17\u201328","journal-title":"Annu Rev Med"},{"key":"BFncpendmet0324_CR81","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ng0198-45","volume":"18","author":"W Siffert","year":"1998","unstructured":"Siffert W et al. (1998) Association of a human G-protein \u03b23 subunit variant with hypertension. Nat Genet 18: 45\u201348","journal-title":"Nat Genet"}],"container-title":["Nature Clinical Practice Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0324","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpendmet0324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T18:00:52Z","timestamp":1707415252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpendmet0324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":81,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["BFncpendmet0324"],"URL":"https:\/\/doi.org\/10.1038\/ncpendmet0324","relation":{},"ISSN":["1745-8366","1745-8374"],"issn-type":[{"value":"1745-8366","type":"print"},{"value":"1745-8374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}